PlainRecalls
FDA Drug Moderate Class II Terminated

Oxytocin Injection, USP, (Synthetic), 10 USP Units/mL, for IV Infusion or IM Use, Rx Only, 1 mL vial, APP ) 10 USP Units/mL, 1 mL, APP Pharmaceuticals, LLC Schaumburg, IL, 60173, NDC 63323-012-01.

Reported: July 24, 2013 Initiated: June 24, 2013 #D-804-2013

Product Description

Oxytocin Injection, USP, (Synthetic), 10 USP Units/mL, for IV Infusion or IM Use, Rx Only, 1 mL vial, APP ) 10 USP Units/mL, 1 mL, APP Pharmaceuticals, LLC Schaumburg, IL, 60173, NDC 63323-012-01.

Reason for Recall

Subpotent Drug; 15-month stability test station

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
221,600 vials
Distribution
Nationwide and Puerto Rico
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
Oxytocin Injection, USP, (Synthetic), 10 USP Units/mL, for IV Infusion or IM Use, Rx Only, 1 mL vial, APP ) 10 USP Units/mL, 1 mL, APP Pharmaceuticals, LLC Schaumburg, IL, 60173, NDC 63323-012-01.. Recalled by Fresenius Kabi USA, LLC. Units affected: 221,600 vials.
Why was this product recalled?
Subpotent Drug; 15-month stability test station
Which agency issued this recall?
This recall was issued by the FDA Drug on July 24, 2013. Severity: Moderate. Recall number: D-804-2013.